Unveiling Biocompatibility: Comprehensive Study on Epoxy–Polyetheramine-Based Polymeric Nanogels in CHO-K1 Cell Line
Future Pharmacology · 18.09.2025 · 5 (3) · 54
DOI: 10.3390/futurepharmacol5030054 ↗Kurz gefasst
Fachartikel in der Zeitschrift Future Pharmacology, online erschienen am 18.09.2025. Verfasst von Natalia Nascimento Silveira und 5 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: FAPESP, CNPq.
Abstract (Originalsprache)
Backgorund/Objectives: Advances in nanotechnology have enabled conventional compounds with low bioavailability to achieve their full therapeutic potential by ensuring targeted tissue delivery. In this context, polymeric nanogels have emerged as a promising option for drug delivery due to their high loading capacity and excellent in vivo stability.
Objectives
Given the growing potential of nanogels in drug delivery, their cytotoxicity and genotoxicity must be evaluated to ensure safety in biotechnological applications. This study assessed the genotoxic safety of nanogels synthesized via the reaction of Jeffamine® T-5000 polyoxypropylene triamine (PPO) monomers (Huntsman Chemical, The Woodlands, TX, USA) and poly (ethylene glycol) diglycidyl ether (DPEG) in varying proportions: 1:1 (Nano11), 1:3 (Nano13), and 2:3 (Nano23) PPO/DPEG. Additionally, we determined which of the two components exhibited lower toxicity against the CHO-K1 cell line (Chinese hamster ovary).
Methods
To achieve this, short- and long-term cytotoxicity experiments were conducted using the XTT colorimetric assay and clonogenic survival assay, alongside the micronucleus test and comet assay for genotoxicity analysis.
Results
The cytotoxicity assays (XTT, clonogenic, and trypan blue) indicated that the nanogels did not exhibit cytotoxic effects at concentrations up to 100 μg/mL, while the genotoxicity assays revealed no evidence of DNA or chromosomal damage at these levels.
Conclusions
These findings underscore the safety profile of Jeffamine® T-5000 as an effective carrier, demonstrating its compatibility with DPEG and positioning it as a highly promising and innovative solution for advanced drug delivery systems.
Förderung
- FAPESP
- CNPq
Zitieren
APA
Silveira, N. N., Andrada, H. E., Paulino, J. M., Boaretto, N. C. D. S., Molina, E. F., & Santos, R. A. D. (2025). Unveiling Biocompatibility: Comprehensive Study on Epoxy–Polyetheramine-Based Polymeric Nanogels in CHO-K1 Cell Line. Future Pharmacology, 5(3), 54. https://doi.org/10.3390/futurepharmacol5030054
Vancouver
Silveira NN, Andrada HE, Paulino JM, Boaretto NCDS, Molina EF, Santos RAD. Unveiling Biocompatibility: Comprehensive Study on Epoxy–Polyetheramine-Based Polymeric Nanogels in CHO-K1 Cell Line. Future Pharmacology. 2025;5(3):54. doi:10.3390/futurepharmacol5030054
BibTeX
@article{Silveira2025,
author = {Silveira, Natalia Nascimento and Andrada, Heber Eduardo and Paulino, Julia Mirian and Boaretto, Naiara Cristina da Silva and Molina, Eduardo Ferreira and Santos, Raquel Alves dos},
title = {Unveiling Biocompatibility: Comprehensive Study on Epoxy–Polyetheramine-Based Polymeric Nanogels in CHO-K1 Cell Line},
journal = {Future Pharmacology},
year = {2025},
volume = {5},
number = {3},
pages = {54},
doi = {10.3390/futurepharmacol5030054}
}
EUVIMED